Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON33234Phase 4Active, not recruiting
Phase 4, open-label trial of ropivacaine, sponsored by Leiden University Medical Center. Primary endpoints: Time to initial onset of analgesia at the T3-T4 dermatomes, Time to initial onset of motor blockade and 9 more. Started Sep 2009; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON33234.